ReviewFrontiers in endocrinology2026
Inducing factors and complication risks of pelvic inflammatory disease: a review.
Review in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pelvic inflammatory disease (PID) is a common infectious condition of the female upper genital tract that imposes a substantial global burden on women's reproductive health and overall quality of life. This narrative review aims to comprehensively synthesize current evidence on the inducing factors and complication risks of PID. We conducted a systematic literature search in PubMed, Embase, and Web of Science databases from January 2010 to December 2025, prioritizing high-quality evidence including systematic reviews, meta-analyses, large-scale population-based cohort studies, and national registry data. The review systematically categorizes PID etiologies into sexually transmitted infections, cervicovaginal dysbiosis, iatrogenic procedures (intrauterine device insertion, assisted reproductive technology, and intrauterine manipulations), anatomical abnormalities, underlying gynecological conditions, lifestyle habits, and environmental exposures, with a particular focus on the emerging role of cervicovaginal microbiota in idiopathic PID. Beyond well-established reproductive sequelae such as tubal infertility, ectopic pregnancy, and chronic pelvic pain, we also summarize evidence linking PID to a broad spectrum of under-recognized systemic complications, including ovarian and colorectal cancer, cardiovascular and metabolic disorders, intestinal obstruction, and mental health problems. The findings underscore the critical importance of early diagnosis, appropriate antimicrobial treatment, and comprehensive risk stratification for optimizing clinical outcomes and reducing the long-term burden of PID.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.